Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Meta-Analysis

Chemoprophylaxis Effect of EGCG on the Recurrence of Colorectal Cancer: A Systematic Review and Meta-Analysis

In Press, (this is not the final "Version of Record"). Available online 10 July, 2024
Author(s): Benyu He, Shuhui Kang, Runze Su, Sha Wu, Xue Liu, Maosheng Liu and Si Chen*
Published on: 10 July, 2024

DOI: 10.2174/0113816128319678240612114820

Price: $95

Abstract

Background and Aims: The recurrence rate of Colorectal Cancer (CRC) after cure is always high. The purpose of this study was to investigate whether green tea extract (-)-Epigallocatechin gallate (EGCG) has an effective preventive effect on the recurrence of CRC.

Methods: We conducted a systematic literature review and meta-analysis of the effects of taking EGCG or placebo on disease recurrence in patients after colon polyp removal.

Results: Five Randomized Controlled Trials (RCTs) were included in this review. A double-blind drug trial involving 1389 participants involved EGCG and placebo. The results showed no significant publication bias or heterogeneity in the five studies (I2 = 38%; p = 0.17). Patients taking EGCG had a lower recurrence rate of CRC than those in the placebo group. The results were statistically significant (Z=2.83, p < 0.05).

Conclusion: This study demonstrated that long-term EGCG can prevent CRC recurrence to a certain extent.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy